Target intelligence / Profile preview

RNA, Ro-associated Y1 pseudogene 10 (RNY1P10)

Target
RNY1P10
Molecular classification
Other (Pseudogene; non-coding RNA, RNA gene pseudogene)
01

Overview

RNA, Ro-associated Y1 pseudogene 10 (RNY1P10) is classified as a pseudogene and a non-coding RNA. It corresponds to a non-functional copy of the RNY1 gene, which itself encodes a Y RNA, a small non-coding RNA associated with the Ro ribonucleoprotein complex. As a pseudogene, RNY1P10 does not produce a functional protein but may be transcribed into RNA. In line with mechanistic insights from the broader pseudogene literature, pseudogenes such as RNY1P10 can potentially act as regulators of gene expression at the RNA level: they may function as competitive endogenous RNAs, sponge microRNAs targeting their parent gene, or generate antisense/small interfering RNAs, thus modulating the expression of related mRNAs[1][3][4]. There is currently no evidence that RNY1P10 itself acts as a therapeutic target, nor is there indication that it plays a specific or direct role in human disease. However, pseudogene-derived RNAs as a class may contribute to disease by influencing gene expression networks and could have clinical significance as gene expression biomarkers[3][4][5].

Other names
RNY1P10RNY1 pseudogene 10RNA, Ro-associated Y1 pseudogene 10
02

Mechanism of action

Not applicable (no known therapeutic drugs target this pseudogene; mechanisms described are non-pharmacological and pertain to endogenous regulatory RNA activities.)

03

Biological functions

May participate in regulation of gene expression through RNA-based mechanisms observed for other pseudogenes, such as modulating levels of homologous functional RNAs by acting as decoys for microRNAs (miRNA), producing antisense RNAs, or generating small interfering RNAs (siRNAs) that regulate gene expression via RNA interference
04

Disease associations

Other (There is no direct evidence linking RNY1P10 to specific diseases; pseudogenes in general may be involved in disease by modulating parental gene expression or serving as disease biomarkers.)

Beyond the preview

Go deeper on RNA, Ro-associated Y1 pseudogene 10 (RNY1P10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, Ro-associated Y1 pseudogene 10 (RNY1P10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call